Cargando…

Platform trials as the way forward in infectious disease’ clinical research: the case of coronavirus disease 2019

Detalles Bibliográficos
Autores principales: Pericàs, Juan M., Derde, Lennie P.G., Berry, Scott M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711898/
https://www.ncbi.nlm.nih.gov/pubmed/36462745
http://dx.doi.org/10.1016/j.cmi.2022.11.022
_version_ 1784841678528446464
author Pericàs, Juan M.
Derde, Lennie P.G.
Berry, Scott M.
author_facet Pericàs, Juan M.
Derde, Lennie P.G.
Berry, Scott M.
author_sort Pericàs, Juan M.
collection PubMed
description
format Online
Article
Text
id pubmed-9711898
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-97118982022-12-01 Platform trials as the way forward in infectious disease’ clinical research: the case of coronavirus disease 2019 Pericàs, Juan M. Derde, Lennie P.G. Berry, Scott M. Clin Microbiol Infect Commentary European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023-03 2022-12-01 /pmc/articles/PMC9711898/ /pubmed/36462745 http://dx.doi.org/10.1016/j.cmi.2022.11.022 Text en © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Pericàs, Juan M.
Derde, Lennie P.G.
Berry, Scott M.
Platform trials as the way forward in infectious disease’ clinical research: the case of coronavirus disease 2019
title Platform trials as the way forward in infectious disease’ clinical research: the case of coronavirus disease 2019
title_full Platform trials as the way forward in infectious disease’ clinical research: the case of coronavirus disease 2019
title_fullStr Platform trials as the way forward in infectious disease’ clinical research: the case of coronavirus disease 2019
title_full_unstemmed Platform trials as the way forward in infectious disease’ clinical research: the case of coronavirus disease 2019
title_short Platform trials as the way forward in infectious disease’ clinical research: the case of coronavirus disease 2019
title_sort platform trials as the way forward in infectious disease’ clinical research: the case of coronavirus disease 2019
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711898/
https://www.ncbi.nlm.nih.gov/pubmed/36462745
http://dx.doi.org/10.1016/j.cmi.2022.11.022
work_keys_str_mv AT pericasjuanm platformtrialsasthewayforwardininfectiousdiseaseclinicalresearchthecaseofcoronavirusdisease2019
AT derdelenniepg platformtrialsasthewayforwardininfectiousdiseaseclinicalresearchthecaseofcoronavirusdisease2019
AT berryscottm platformtrialsasthewayforwardininfectiousdiseaseclinicalresearchthecaseofcoronavirusdisease2019
AT platformtrialsasthewayforwardininfectiousdiseaseclinicalresearchthecaseofcoronavirusdisease2019